EquitAI LogoEquitAI
$100.97
-0.01%
LNTH

LNTH

Lantheus Holdings, Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
3/10
Quality
10/10
Growth
4/10
Strength
9/10
Dividend
1/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
Healthy
Earnings
Growth
Dividend Yield
0.00%
Market Cap
$6.59B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Lantheus Holdings develops and manufactures medical imaging agents and targeted therapeutics used primarily in oncology and cardiology. Their products help doctors identify diseases like prostate cancer earlier and see ultrasound images more clearly. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...